MCCLUNG DAVID MARK (EVP Chief Business Officer) reported 1 transaction at SANGAMO THERAPEUTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 6/26/2023ACC: 0001209191-23-039711
Officer· EVP Chief Business Officer
Since May 2020
-11.53K
Net shares
Net seller
$13.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
11.53K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.53K
Price / share
$1.19
Trade value
$13.72K
% of position
5.2%
6/25/2023
222.85K→211.32K
Total
Net shares
−11.53K
Net value
-$13.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2023 | F · Tax Withholding | −11.53K | $1.19 | $13.72K | 5.2% | 222.85K | 211.32K |
| Total | −11.53K | -$13.72K | ||||||
Derivative Transactions0
No derivative transactions reported